Tae Heon Kim

Samsung (South Korea), Samsung Medical Center

Papers

2

Total Citations

76

H-Index

2

About

Tae Heon Kim is a leading urologic oncologist whose research focuses on optimizing surgical outcomes and quality of life for patients with genitourinary cancers, particularly bladder and prostate cancer. His most cited work, a 2016 study with 43 citations, provides critical comparative oncological outcomes among open, laparoscopic, and robot-assisted radical cystectomy for muscle-invasive bladder cancer, helping to guide surgical decision-making. Dr. Kim also made a foundational contribution to patient-centered care by leading the development and validation of the Korean version of the Expanded Prostate Cancer Index Composite (EPIC) in 2010, a widely used tool that has enabled culturally relevant assessment of health-related quality of life after prostate cancer treatment. With 33 citations, this work has been instrumental in standardizing patient-reported outcomes in Korean populations. Through these contributions, Dr. Kim has advanced both the technical and humanistic dimensions of urologic oncology, bridging surgical innovation with rigorous quality-of-life measurement to improve long-term patient well-being.

Research Focus

Key Achievements

2
H-Index
2
Papers
76
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches
43 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Samsung (South Korea), Samsung Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago